AI Article Synopsis

  • * A documented case describes a mature woman who developed MOGAD following adenoviral meningitis one month post-childbirth, which was treated successfully with high-dose methylprednisolone.
  • * This case indicates that there may be a higher risk of developing MOGAD shortly after childbirth and suggests a possible connection between adenoviral infections and the onset of MOGAD.

Article Abstract

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a group of central nervous system (CNS) demyelinating diseases caused by autoantibodies against myelin oligosaccharide protein (MOG), a myelin sheath component protein, and present with a variety of symptoms, including optic neuritis, myelitis, acute disseminated encephalomyelitis (ADEM), brainstem encephalitis, and corticobasal encephalitis. It is currently unknown at what point in life MOGAD can develop or how it can be triggered by autoimmune mechanisms. Here, we report a case of a mature woman who suffered from adenoviral meningitis one month after childbirth and developed MOGAD but was able to return to child rearing with high-dose methylprednisolone therapy. This case suggests that the risk of developing MOGAD early after childbirth may be increased. The case also suggested that adenoviral infection may be involved in the development of MOGAD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10699203PMC
http://dx.doi.org/10.7759/cureus.48364DOI Listing

Publication Analysis

Top Keywords

myelin oligodendrocyte
8
oligodendrocyte glycoprotein
8
glycoprotein antibody-associated
8
antibody-associated disease
8
disease mogad
8
mogad
6
myelin
4
mogad adenovirus
4
adenovirus meningitis
4
meningitis delivery
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!